Last edition
News about
Bayer to Showcase Low-Dose MRI Contrast Innovation at ECR 2026
Bayer brings next-generation contrast agents and smart radiology solutions to ECR 2026, spotlighting progress in low-dose MRI imaging and clinical innovation.
European Commission Expands Bracco's Vueway Approval to Infants and Neonates
Bracco Imaging secures EU approval to extend Vueway’s use to infants and neonates, enhancing safe and effective MRI diagnostics for young patients.
Davaindia Launches 77 New Stores Nationwide to Mark India's 77th Republic Day
The expansion by Zota Healthcare’s generic pharmacy chain strengthens access to affordable medicines across metros and Tier II and III cities under its “Har Ghar Ki Pharmacy” vision.
European Commission Expands GSK's RSV Vaccine Arexvy to Adults Aged 18 and Above
GSK’s RSV vaccine Arexvy receives European approval for adults aged 18 plus, marking a major expansion in protection against RSV-related respiratory illness across the region.
India - EU FTA Must Ensure Level Playing Field for Medical Device Makers: AiMeD
The proposed India–European Union Free Trade Agreement (FTA) has the potential to reshape India’s pharmaceutical and medical devices landscape, but industry leaders caution that its success will depend on how fairly it balances market access, regulatory alignment and domestic manufacturing interests.
Siegfried Expands U.S. Manufacturing Capacity with Acquisition of Two Facilities
Siegfried, the Switzerland-based contract development and manufacturing organisation (CDMO), is expanding its manufacturing presence in the United States through the acquisition of two pharmaceutical production facilities.
India's OTC Market Projected to Reach INR 98,000 Crore by 2030, EY Report Says
A new report by EY projects that India’s over-the-counter (OTC) drug market is expected to nearly double by 2030, reaching INR 98,000 crore, up from around INR 47,000 crore in 2024, growing at a compound annual growth rate of about 13 per cent.
EU Trade Pact Set to Boost Indian Pharma and Medical Device Exports
The recently finalised India–European Union Free Trade Agreement (FTA) is expected to significantly expand opportunities for India’s pharmaceutical and medical technology sectors by opening access to a USD 572 billion European healthcare market, Union Health Minister J.P. Nadda said.
Union Health Ministry Revises NDCT Rules
The Union Health Ministry has notified amendments to the NDCT Rules, 2019 to ease compliance and speed up drug development, introducing a prior-intimation mechanism in place of licensing, waiving permissions for select low-risk BA/BE studies, and cutting test licence processing timelines to 45 days.
Pharma Leaders Outline Key Expectations Ahead of Union Budget 2026
Pharma industry leaders are urging the government to simplify GST on essential medicines, improve ease of doing business, enable easier access to long-term capital and provide greater policy clarity, amid more, in the upcoming Union Budget 2026.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy